A Study to Compare Zavegepant Concentration Using Samples Collected From the Vein Versus Patient-Centric Microsampling

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 10, 2023

Primary Completion Date

September 5, 2023

Study Completion Date

September 5, 2023

Conditions

Healthy

Interventions

DRUG

Zavegepant 10 mg IN

All participants will receive zavegepant 10 mg IN spray in period 1 and a butterscotch candy + zavegepant 10 mg IN spray in period 2

Trial Locations (1)

Pfizer Clinical Research Unit - New Haven, New Haven